Silo Pharma Inc.

NASDAQ: SILO · Real-Time Price · USD
0.71
0.02 (2.59%)
At close: Aug 15, 2025, 3:59 PM
0.71
-0.63%
After-hours: Aug 15, 2025, 07:49 PM EDT

Silo Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
4.33M 3.14M 3.91M 4.86M 4.51M 2.67M 3.52M 199.84K 158.83K 4.67M 11.37M 12.25M 8.73M 9.07M 9.84M 10.26M 4.15M 4.64M
Short-Term Investments
1.93M 2.31M 3.17M 3.15M 3.1M 4.08M 4.14M 8.57M 9.83M 6.02M 3.12K 77.94K 113.01K 343.93K 420K 820.13K 600.2K 570.2K
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 64.8K 63.59K 62.39K 61.21K 60K n/a n/a
Other Long-Term Assets
-6.32M 57.69K 59.15K 60.6K 62.06K 63.52K 64.98K 66.44K 67.9K 69.36K 70.82K 72.28K 33.74K 35.2K 26.66K 28.12K 29.58K 19.38K
Receivables
n/a n/a n/a n/a n/a n/a n/a 69.6K 68.39K 67.19K 66.01K n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -63.59K -62.39K n/a -60K 55.61K 44.66K
Other Current Assets
113.06K 152.73K 30.96K 246.45K 120.29K 133.76K 15.97K 79.91K 121.33K 204.35K n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
6.37M 5.6M 7.11M 8.26M 7.73M 6.88M 7.68M 8.92M 10.18M 10.95M 11.57M 12.91M 8.95M 9.62M 10.4M 11.3M 4.97M 5.48M
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
223.25K 238.12K 241.22K 244.31K 247.4K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
-6.09M 295.81K 300.36K 304.91K 309.46K 63.52K 64.98K 66.44K 67.9K 69.36K 70.82K 137.09K 97.33K 97.59K 87.87K 88.12K 29.58K 19.38K
Total Assets
279.48K 5.9M 7.41M 8.57M 8.04M 6.94M 7.75M 8.99M 10.25M 11.02M 11.64M 13.05M 9.04M 9.72M 10.49M 11.39M 5M 5.5M
Account Payables
n/a 1.11M 1.58M 972.73K 1.25M 801.57K 703.49K 606.67K 1.05M 660.28K 364.22K 223.65K 155.92K 155.81K 417.94K 211.29K 192.03K 238.04K
Deferred Revenue
72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 68.75K
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 17.84K
Other Current Liabilities
977.79K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 16.45K 40.82K 64.84K n/a n/a n/a 2.37K
Total Current Liabilities
1.05M 1.19M 1.66M 1.04M 1.32M 873.67K 775.59K 678.77K 1.12M 732.38K 436.32K 312.19K 268.85K 292.75K 490.04K 283.39K 264.13K 326.99K
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.06K
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
n/a 703.55K 721.58K 739.6K 757.63K 775.65K 793.68K 811.71K 829.73K 847.76K 865.78K 883.81K 901.83K 919.86K 937.88K 955.91K 973.93K 946.38K
Total Liabilities
685.53K 1.89M 2.38M 1.78M 2.08M 1.65M 1.57M 1.49M 1.95M 1.58M 1.3M 1.2M 1.17M 1.21M 1.43M 1.24M 1.24M 1.27M
Total Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 18.9K
Common Stock
865.00 449.00 449.00 449.00 408.00 316.00 316.00 311.00 311.00 316.00 316.00 314.00 9.94K 9.94K 9.86K 9.86K 9.86K 8.51K
Retained Earnings
-17.5M -16.3M -15.26M -13.53M -12.61M -11.67M -10.87M -9.75M -9.09M -8.08M -7.17M -5.51M -4.53M -3.87M -3.26M -2.17M -8.56M -8.1M
Comprehensive Income
9.56K 10.7K 2.42K 19.8K 8.03K 26.1K -6.23K -723 -3.28K 5.24K n/a n/a n/a -49.91K n/a n/a n/a n/a
Shareholders Equity
4.92M 4.01M 5.03M 6.78M 5.96M 5.29M 6.18M 7.5M 8.3M 9.44M 10.34M 11.85M 7.87M 8.5M 9.06M 10.15M 3.77M 4.23M
Total Investments
n/a 2.31M 3.17M 3.15M 3.1M 4.08M 4.14M 8.57M 9.83M 6.02M 3.12K 77.94K 113.01K 343.93K 420K 820.13K 600.2K 570.2K